
15 Percent Quarterly Revenue Growth Stocks to Buy in November 2026: 5 Names on the Watchlist
Adani Ports Rs 1,943. Central Bank of India Rs 31.23. ICICI Bank Rs 1,589. Metropolis Healthcare Rs 582.35. Tata Steel Rs 184.85. NSE closing prices, 9 Nov 2026.
Updated: 10 Nov 2026 • 11:54 am
Posted by:

Quick Answer
Five 15 percent quarterly revenue growth stocks to buy on the November 2026 watchlist are Adani Ports and Special Economic Zone, Central Bank of India, ICICI Bank, Metropolis Healthcare and Tata Steel. All five grew revenue in their latest full year, and all five also grew net profit. Central Bank of India has the lowest P/E at 5.48, while ICICI Bank leads on return on equity at 15.39%. Check each valuation against your own risk appetite before acting.
The 15 percent quarterly revenue growth stocks to buy in November 2026 start with five listed names: Adani Ports and Special Economic Zone, Central Bank of India, ICICI Bank, Metropolis Healthcare and Tata Steel. These five companies each grew revenue by about 14% to 16% in the September 2026 quarter compared with a year earlier. Tata Steel is part of the Nifty Metal index and ICICI Bank is part of the Bank Nifty index.
This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these 15 percent quarterly revenue growth stocks to buy to a portfolio. All prices are NSE closing prices of 9 November 2026, and financials come from company filings.
Click Here – Get Free Investment Predictions
Which Are the Best 15 Percent Quarterly Revenue Growth Stocks to Buy in November 2026?
The best 15 percent quarterly revenue growth stocks to buy in November 2026 for a watchlist are Adani Ports and Special Economic Zone, Central Bank of India, ICICI Bank, Metropolis Healthcare and Tata Steel. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.
| Company | CMP (Rs) | Market Cap | P/E | ROE | Dividend Yield |
|---|---|---|---|---|---|
| Adani Ports and Special Economic Zone | 1,943 | Rs 4,26,232 crore | 31.15 | 13.33% | 0.41% |
| Central Bank of India | 31.23 | Rs 26,448 crore | 5.48 | 12.76% | 6.16% |
| ICICI Bank | 1,589 | Rs 9,86,882 crore | 15.71 | 15.39% | 0.87% |
| Metropolis Healthcare | 582.35 | Rs 11,493 crore | 56.65 | 12.56% | 0.90% |
| Tata Steel | 184.85 | Rs 2,11,596 crore | 18.79 | 10.56% | 2.36% |
On valuation, Central Bank of India trades below the industry P/E; Adani Ports and Special Economic Zone, Metropolis Healthcare and Tata Steel sit close to it; ICICI Bank carries a premium. Valuation is the first filter for any 15 percent quarterly revenue growth stocks to buy list, and it is covered again in the risk section.
Why These 15 Percent Quarterly Revenue Growth Stocks to Buy Are in Focus
In this list, FY26 net profit and revenue both grew for every company, and quarterly profit in the September 2026 quarter was higher than a year earlier for all five. The list covers a public sector bank, a large steel producer, a diagnostics chain, a private sector bank and India's largest private port operator. Investors comparing the best stocks with fifteen percent quarterly revenue growth in India usually check whether sales growth turns into profit, how the shares are valued and how much debt the company carries.
Adani Ports and Special Economic Zone: The Port Operator Among 15 Percent Quarterly Revenue Growth Stocks to Buy
Adani Ports and Special Economic Zone is India's largest port operator, with ports and logistics services. The stock trades at Rs 1,943 with a market capitalisation of Rs 4,26,232 crore and a P/E of 31.15, against an industry P/E of 30.60.
FY26 revenue rose 26.2% to Rs 40,854 crore and net profit rose 15.6% to Rs 12,782 crore. In the September 2026 quarter, revenue grew 16.1% year on year to Rs 11,610 crore, while net profit grew 18.0% to Rs 3,682 crore.
Return on equity is 13.33%, debt-to-equity is 0.65, and the dividend yield is 0.41%. Promoters hold 66.03%, foreign institutions 15.95% and domestic institutions 13.25% as of September 2026. Foreign institutional holding has risen from 13.61% to 15.95% over the last year.
Central Bank of India: The Low-Priced Public Sector Bank Among 15 Percent Quarterly Revenue Growth Stocks to Buy
Central Bank of India is a public sector bank with a large branch network in central and eastern India. At Rs 31.23, the stock has a market capitalisation of Rs 26,448 crore and trades at 5.48 times earnings, while the industry P/E is 11.45.
Reported numbers show FY26 revenue of Rs 42,583 crore, up 7.9% year on year, with net profit at Rs 4,531 crore, up 14.9%. The September 2026 quarter added revenue of Rs 11,774 crore (up 14.9%) and net profit of Rs 1,475 crore (up 21.0%).
Return on equity is 12.76%, and the dividend yield is 6.16%. Promoters hold 81.19%, foreign institutions 1.29% and domestic institutions 10.62% as of September 2026. Domestic institutional holding has risen from 4.83% to 10.62% over the last year.
Check 15 Percent Quarterly Revenue Growth Stocks Live on the Univest Screener
ICICI Bank: The Retail Banking Strong Suit Among 15 Percent Quarterly Revenue Growth Stocks to Buy
ICICI Bank is a large private bank known for retail lending and digital banking. Its market capitalisation is Rs 9,86,882 crore, the share price is Rs 1,589 and the P/E of 15.71 compares with an industry P/E of 11.43.
Over FY26, net profit rose 6.0% to Rs 57,673 crore on revenue of Rs 3,12,118 crore, which was up 6.0%. The latest quarter, the September 2026 quarter, brought revenue of Rs 88,161 crore, up 15.8% year on year, and net profit of Rs 17,312 crore, up 21.4%.
Return on equity is 15.39%, and the dividend yield is 0.87%. The company has no identified promoter, with foreign institutions holding 50.44% and domestic institutions 41.78% as of September 2026. Foreign institutional holding has risen from 45.56% to 50.44% over the last year.
Metropolis Healthcare: The Diagnostics Network Among 15 Percent Quarterly Revenue Growth Stocks to Buy
Metropolis Healthcare is a diagnostics company with labs and collection centres across India and overseas. The stock trades at Rs 582.35 with a market capitalisation of Rs 11,493 crore and a P/E of 56.65, against an industry P/E of 61.50.
FY26 revenue rose 24.1% to Rs 1,671 crore and net profit rose 31.4% to Rs 191 crore. In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit grew 25.7% to Rs 56.9 crore.
Return on equity is 12.56%, debt-to-equity is 0.15, and the dividend yield is 0.90%. Promoters hold 47.82%, foreign institutions 11.67% and domestic institutions 35.49% as of September 2026. Domestic institutional holding has risen from 33.10% to 35.49% over the last year.
Tata Steel: The Integrated Steel Major Among 15 Percent Quarterly Revenue Growth Stocks to Buy
Tata Steel is a large integrated steel producer with operations in India and overseas. At Rs 184.85, the stock has a market capitalisation of Rs 2,11,596 crore and trades at 18.79 times earnings, while the industry P/E is 19.82.
Reported numbers show FY26 revenue of Rs 2,33,542 crore, up 6.1% year on year, with net profit at Rs 10,886 crore, up 243.0%. The June 2026 quarter added revenue of Rs 61,027 crore (up 14.1%) and net profit of Rs 2,385 crore (up 18.8%).
Return on equity is 10.56%, debt-to-equity is 0.90, and the dividend yield is 2.36%. Promoters hold 32.95%, foreign institutions 17.72% and domestic institutions 25.18% as of September 2026.
Download the Univest iOS App or Univest Android App to track these 15 percent quarterly revenue growth stocks live and get daily stock recommendations.
Growth Snapshot: Latest Full Year and Latest Quarter
The table compares year-on-year growth in revenue and net profit for all five 15 percent quarterly revenue growth stocks, using filed results.
| Company | Full-Year Revenue Growth | Full-Year Profit Growth | Latest Quarter | Quarter Revenue Growth | Quarter Profit Growth |
|---|---|---|---|---|---|
| Adani Ports and Special Economic Zone | 26.2% | 15.6% | Sep 2026 | 16.1% | 18.0% |
| Central Bank of India | 7.9% | 14.9% | Sep 2026 | 14.9% | 21.0% |
| ICICI Bank | 6.0% | 6.0% | Sep 2026 | 15.8% | 21.4% |
| Metropolis Healthcare | 24.1% | 31.4% | Jun 2026 | 15.7% | 25.7% |
| Tata Steel | 6.1% | 243.0% | Jun 2026 | 14.1% | 18.8% |
Factors That Move 15 Percent Quarterly Revenue Growth Stocks to Buy
Four factors tend to drive 15 percent quarterly revenue growth stocks, and each one is worth checking before a purchase.
- Quarterly growth: Revenue rose about 14% to 16% year on year.
- Dividends: Central Bank of India yields about 6.2%.
- Return on equity: ICICI Bank leads at about 15%.
- Valuation: P/E runs from about 5 to 57.
Risks to Keep in Mind Before Buying 15 Percent Quarterly Revenue Growth Stocks
The first risk is that Metropolis Healthcare trades at a P/E near 57 while Central Bank of India trades near 5, so expectations differ widely. The second is that steel earnings follow global prices and Tata Steel carries the highest borrowings of the five. Check results every quarter.
On the numbers, Metropolis Healthcare trades at the highest P/E on this list at 56.65, so its earnings need to keep growing to support the price. 15 Percent Quarterly Revenue Growth stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.
How to Choose 15 Percent Quarterly Revenue Growth Stocks to Buy
- Compare growth: Metropolis Healthcare grew FY26 profit most, by about 31%.
- Check P/E: Central Bank of India trades lowest.
- Read the yield: Central Bank of India pays the most.
- Spread sectors: Mix banking, steel, diagnostics and ports.
How to Invest in 15 Percent Quarterly Revenue Growth Stocks
- Shortlist two or three companies from this list that match your risk appetite.
- Open the Univest Screener and compare P/E, ROE and debt for each stock.
- Check the latest quarterly results and shareholding pattern on NSE or BSE.
- Decide an amount you can hold for three to five years and split it into two or three purchases.
- Review the holding after every quarterly result instead of reacting to daily price moves.
Conclusion
Central Bank of India offers the lowest P/E on this list at 5.48, ICICI Bank has the highest return on equity at 15.39%, and Tata Steel posted the fastest net profit growth in its latest full year at 243.0%. Among the best 15 percent quarterly revenue growth stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these 15 percent quarterly revenue growth stocks to buy.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on 15 Percent Quarterly Revenue Growth Stocks to Buy
Which are the best 15 percent quarterly revenue growth stocks to buy in November 2026?
Ans. The five 15 percent quarterly revenue growth stocks on the November 2026 watchlist are Adani Ports and Special Economic Zone, Central Bank of India, ICICI Bank, Metropolis Healthcare and Tata Steel. Central Bank of India has the lowest P/E at 5.48, ICICI Bank has the highest ROE at 15.39%, and Tata Steel grew net profit 243.0% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.
Is ICICI Bank a good stock to buy from this 15 Percent Quarterly Revenue Growth list?
Ans. ICICI Bank is the largest company on this list with a market capitalisation of Rs 9,86,882 crore and a P/E of 15.71 against an industry P/E of 11.43. Its FY26 revenue rose 6.0% and net profit rose 6.0%, with return on equity at 15.39%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.
Are these 15 percent quarterly revenue growth stocks expensive right now?
Ans. Valuations vary across the group. Adani Ports and Special Economic Zone trades at a P/E of 31.15, Central Bank of India trades at a P/E of 5.48, ICICI Bank trades at a P/E of 15.71, Metropolis Healthcare trades at a P/E of 56.65, Tata Steel trades at a P/E of 18.79, against industry multiples ranging from 11.43 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.
Which of these 15 percent quarterly revenue growth stocks pay a dividend?
Ans. Dividend yields on this list are Adani Ports and Special Economic Zone 0.41%, Central Bank of India 6.16%, ICICI Bank 0.87%, Metropolis Healthcare 0.90%, Tata Steel 2.36%. Yields differ widely across the group, so check payout history and earnings cover before relying on any of them for income, since payouts can change with company profits.
Which stock on this list has the highest return on equity?
Ans. ICICI Bank has the highest ROE on this list at 15.39%, followed by Adani Ports and Special Economic Zone at 13.33% and Central Bank of India at 12.76%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.
What are the risks of investing in 15 percent quarterly revenue growth stocks?
Ans. The main risks are steel price swings, asset quality at the banks and one high valuation. On this list, Metropolis Healthcare trades at the highest P/E of 56.65, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.
How can I invest in 15 percent quarterly revenue growth stocks in India?
Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.
Recent Articles

3 Global Pharmaceutical Company, Line Pipes Maker and Power Plant Maintenance Services Company Stocks With a Strong Future Roadmap: Sun Pharma, Welspun Corp and Power Mech Projects
10 November 2026

3 Plastic Pipes and Products Maker, Animal Feed and Agri Business Company and Software Services Company Stocks With a Strong Future Roadmap: Supreme Industries, Godrej Agrovet and Sonata Software
10 November 2026

3 Winding Wires Maker, Lubricants Company and Steam Turbines Maker Stocks With a Strong Future Roadmap: Ram Ratna Wires, Gulf Oil Lubricants India and Triveni Turbine
10 November 2026

3 Fermentation Based Pharma Ingredients Maker, Defence Electronics Company and Personal Care Brands Company Stocks With a Strong Future Roadmap: Concord Biotech, Bharat Electronics and Honasa Consumer
10 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
3 Global Pharmaceutical Company, Line Pipes Maker and Power Plant Maintenance Services Company Stocks With a Strong Future Roadmap: Sun Pharma, Welspun Corp and Power Mech Projects
3 Plastic Pipes and Products Maker, Animal Feed and Agri Business Company and Software Services Company Stocks With a Strong Future Roadmap: Supreme Industries, Godrej Agrovet and Sonata Software
3 Winding Wires Maker, Lubricants Company and Steam Turbines Maker Stocks With a Strong Future Roadmap: Ram Ratna Wires, Gulf Oil Lubricants India and Triveni Turbine
3 Fermentation Based Pharma Ingredients Maker, Defence Electronics Company and Personal Care Brands Company Stocks With a Strong Future Roadmap: Concord Biotech, Bharat Electronics and Honasa Consumer
3 Garments and Textiles Maker, Express Logistics Company and Steel Tubes and Forgings Maker Stocks With a Strong Future Roadmap: KPR Mill, Blue Dart Express and Goodluck India
Popular this week
3 Ethnic Foods Exporter, Packaging Products Maker and Iron Ore Producer Stocks With a Strong Future Roadmap: ADF Foods, TCPL Packaging and NMDC

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





